Showing results (161-170 of 206) with videos related to
Sort By:
Pageof 21
Journal of Neuro-Aids|January 1, 1996
Macrophage Activation Factorsin the Brains of AIDS PatientsC L Achim, E Masliah, M P Heyes, et al.Journal of Neurochemistry|September 1, 1994
Cerebrospinal fluid nitrite/nitrate levels in neurologic diseasesS Milstien, N Sakai, B J Brew, et al.Journal of Neurochemistry|January 1, 1996
Increased brain levels of platelet-activating factor in a murine acquired immune deficiency syndrome are NMDA receptor-mediatedK Nishida, S P Markey, Y Kustova, et al.European Journal of Pharmacology|April 20, 1984
Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the ratC C Chiueh, S P Markey, R S Burns, et al.Journal of Racial and Ethnic Health Disparities|December 5, 2022
COVID-19 Pandemic Associations on Mental and Physical Health in African Americans Participating in a Behavioral InterventionJ A Bernhart, A W Fellers, M J Wilson, et al.The Biochemical Journal|January 1, 1997
Marked increases in concentrations of apolipoprotein in the cerebrospinal fluid of poliovirus-infected macaques: relations between apolipoprotein concentrations and severity of brain injuryK Saito, M Seishima, M P Heyes, et al.Arthritis and Rheumatism|September 1, 1992
Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndromeR M Silver, K McKinley, E A Smith, et al.Brain Research. Developmental Brain Research|December 21, 1995
Evidence of excitotoxicity in the brain of the ornithine carbamoyltransferase deficient sparse fur mouseM B Robinson, K Hopkins, M L Batshaw, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1983
A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridineR S Burns, C C Chiueh, S P Markey, et al.Archives of General Psychiatry|February 1, 1988
Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin outputR N Golden, S P Markey, E D Risby, et al.Pageof 21